Persistent Shortages of Life-Saving Cancer Drugs Plague US Medical Centers
A survey conducted by the National Comprehensive Cancer Network reveals that major cancer centers in the US are still facing widespread shortages of critical chemotherapy drugs. Among the surveyed centers, 72% reported a shortage of carboplatin and 59% reported a shortage of cisplatin, both of which are commonly used in cancer treatment. Overall, 86% of the centers reported a shortage of at least one type of anti-cancer drug. The ongoing drug shortages, which have been exacerbated this year, are a cause for concern as they impact access to the best possible treatment for cancer patients. The survey highlights the need for enduring solutions to address these shortages and ensure equitable care for all cancer patients.
